NIH-funded research NIH-funded research

How brevican changes nerve cell excitability in the brain

Official title: The effect of brevican glycosylation on neuronal excitability

Funded at University of Mississippi · NIH-11569096 · Data updated 2026-11-12

A small NIH grant is exploring how a brain protein called brevican, and its sugar tags, affect nerve cell activity in a specific brain area tied to fear and stress.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Mississippi
NIH-funded
Lab location1 site (University, United States)
Project startMay 15, 2020
Project endMay 31, 2030
Funding year2026
Award (this year)$182,755
NIH project number5P20GM130460-07
Project IDNIH-11569096 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates would be individuals with conditions related to abnormal threat processing or stress responses, where future therapies might aim to modulate specific brain pathways.

Less likely to help

There may be no direct benefit to patients from this basic, early-stage research.

What this research studies

This project will use brain slices to study how brevican glycosylation affects the activity of fast-spiking neurons in the anterior hypothalamic area, which helps relay threat information. The researchers will apply precise cellular techniques and patch-clamp recordings to measure neuron excitability under different glycosylation states. By manipulating brevican in controlled experiments, they aim to uncover mechanisms that modulate downstream brain circuits involved in behavior and emotion. The work could reveal molecular targets that influence how the brain processes threat-related signals.

Why it matters

Potential benefit: If successful, this work could inform future approaches to managing fear- and stress-related brain functions by targeting specific brain cell interactions.

How similar studies have gone: Previous work shows brevican and perineuronal nets influence neuron excitability in other brain regions, supporting the potential relevance of this approach.

Where this research is happening

  • University of Mississippi
    University, United States
    Active

Researchers

  • Principal investigator: Laing, Brenton — University of Mississippi
  • Study coordinator: Laing, Brenton

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.